The antiserum was produced against synthesized peptide derived from human LRRC41.
Alternative Names:
elongin BC-interacting leucine-rich repeat protein,leucine-rich repeat-containing protein 41,MUF1,MUF1 protein (MUF1),PP7759,protein Muf1.
Probable substrate recognition component of an ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.
